Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS
- PMID: 39102621
- DOI: 10.1182/blood.2024024351
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS
Abstract
HLA-DP permissive mismatches can be assigned a direction according to their immunopeptidome divergence across core and noncore subsets. Noncore permissive graft-versus-host mismatches show significantly reduced risks of relapse without increased nonrelapse mortality compared with allele-matched pairs.
© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Comment in
-
New HLA-DPB1 T-cell epitope model for mismatched UR-HCT.Blood. 2024 Oct 17;144(16):1659-1661. doi: 10.1182/blood.2024026286. Blood. 2024. PMID: 39418035 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous